Signify Health expands in-home diagnostics for patients with heart arrhythmias

February 29, 2024- Signify Health, a CVS Health® company, announced the addition of a heart arrhythmia test to its Diagnostic and Preventive Services offering. This screening broadens the Signify Health range of in-home services designed to support earlier detection, diagnosis and management of the most prevalent medical conditions impacting people’s health.

The prevalence of heart arrhythmias, or irregular heartbeat, is expected to grow because of the aging U.S. population. Atrial Fibrillation (AFib) is the most common arrhythmia, with an estimated one-third of adults being asymptomatic and 1.26-1.52M cases being undiagnosed.

Screenings for heart arrhythmias via the Continuous ECG patch can improve the member experience and drive quality outcomes. Studies have shown that 94% of people found the patch more comfortable to wear versus 52% for a Holter monitor – and that a 14-day ECG is two times as effective as a Holter monitor.

Learn More

safe online pharmacy for viagra cheap kamagra oral jelly online